Previous 10 | Next 10 |
NRx Pharmaceuticals Closes $11 Million Unsecured Debt Financing PR Newswire RADNOR, Pa. , Nov. 7, 2022 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals" or the "Company"), a clinical-stage CNS biopharmaceutical company, today...
NRx Pharmaceuticals Leaders to Present at the H.C. Wainwright & Co. 24th Annual Global Investment Conference NRx Pharmaceuticals Leaders to Present at the H.C. Wainwright & Co. 24th Annual Global Investment Conference PR Newswire Company to Present Corporat...
RELIEF THERAPEUTICS HOLDING SA AND NRX PHARMACEUTICALS, INC. ANNOUNCE TENTATIVE SETTLEMENT OF PENDING LITIGATION PR Newswire Release of an ad hoc announcement pursuant to Art. 53 LR GENEVA and RADNOR, Pa. , Aug. 22, 2022 /PRNewswire/ -- ...
NRx Pharmaceuticals, Inc. (NRXP) Q2 2022 Earnings Conference Call August 15, 2022 08:30 AM ET Company Participants Tom Johnson - Investor Relations Stephen Willard - Chief Executive Officer Seth Van Voorhees - Chief Financial Officer & Treasurer Robert Be...
NRx Pharmaceuticals press release ( NASDAQ: NRXP ): Q2 Net loss of $7M As of June 30, 2022, cash was $24.5 million compared to $27.6 million as of December 31, 2021.The company believes that they have sufficient funds and if necessary, the ability to reduce expenditures, t...
NRx Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Results Focusing on Reactivation & Advancement of its Psychiatry Franchise NRx Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Results Focusing on Reactivation & Advance...
/C O R R E C T I O N -- NRx Pharmaceuticals, Inc./ PR Newswire In the news release, NRx Pharmaceuticals to Report Second Quarter 2022 Results on August 15, 2022 , issued Aug. 10, 2022 by NRx Pharmaceuticals, Inc. over PR Newswire, we are advised by the company th...
NRx Pharmaceuticals to Report Second Quarter 2022 Results on August 15, 2022 PR Newswire --Company to Host Conference Call August 15th, 2022 , at 8:30AM ET --- RADNOR, Pa. , Aug. 10, 2022 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq:...
NRx Pharmaceuticals ( NASDAQ: NRXP ) appoints extensive experienced in law, finance, and management of public and private biotechnology companies Stephen Willard as its CEO and a member of the company's board of directors. The company's interim CEO, Robert B...
Clinical-stage Pharma company NRx Pharmaceuticals ( NASDAQ: NRXP ) announced on Friday that the FDA declined to issue its Emergency Use Authorization (EUA) for its COVID-19 therapy Zyesami (aviptadil). NRx ( NRXP ) had sought FDA nod for Zyesami targeting a subgroup of...
News, Short Squeeze, Breakout and More Instantly...
NRX Pharmaceuticals Inc. Company Name:
NRXP Stock Symbol:
NASDAQ Market:
NRX Pharmaceuticals Inc. Website:
NRx Pharmaceuticals (NASDAQ:NRXP) to Proceed with Two New Drug Applications in 2024; NRX-101 has Been Returned to the Company for Filing PR Newswire New Drug Application (NDA) for Accelerated Approval planned for NRX-101 in people with bipolar depression and akathisia in 202...
NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference on June 27, 2024 PR Newswire RADNOR, Pa. , June 20, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals"...
NRx Pharmaceuticals (NASDAQ:NRXP) Appoints Neuroscience, Information Technology and Medical Technology Veteran to its Board of Directors PR Newswire Dr. Dennis McBride brings extensive experience in Neuroscience and its interface with Information and Medical Technology ...